tiprankstipranks
Advertisement
Advertisement

PMN Stock Latest News

ProMIS Neurosciences shareholders approve directors and incentive plan
Company AnnouncementsProMIS Neurosciences shareholders approve directors and incentive plan
15d ago
8K
PMN
ProMIS Neurosciences initiated with a Buy at Brookline
PremiumThe Fly
ProMIS Neurosciences initiated with a Buy at Brookline
15d ago
PMN
ProMIS Neurosciences reports Q1 EPS ($1.26) vs. ($5.27) last year
PremiumThe Fly
ProMIS Neurosciences reports Q1 EPS ($1.26) vs. ($5.27) last year
23d ago
PMN
ProMIS Neurosciences: Strengthened Balance Sheet and Differentiated PMN310 Alzheimer’s Program Underpin Buy Rating
PremiumRatings
ProMIS Neurosciences: Strengthened Balance Sheet and Differentiated PMN310 Alzheimer’s Program Underpin Buy Rating
2M ago
PMN
ProMIS Neurosciences files $200M mixed securities shelf
PremiumThe Fly
ProMIS Neurosciences files $200M mixed securities shelf
2M ago
PMN
ProMIS Neurosciences files to sell 13.83M common shares for holders
PremiumThe FlyProMIS Neurosciences files to sell 13.83M common shares for holders
3M ago
PMN
Promis Neurosciences Inc trading resumes
Premium
The Fly
Promis Neurosciences Inc trading resumes
4M ago
PMN
Promis Neurosciences Inc trading halted, volatility trading pause
Premium
The Fly
Promis Neurosciences Inc trading halted, volatility trading pause
4M ago
PMN
ProMIS Neurosciences Announces $75 Million PIPE Financing
PremiumCompany Announcements
ProMIS Neurosciences Announces $75 Million PIPE Financing
4M ago
8K
PMN
ProMIS Neurosciences exceeds target enrollment in PRECISE-AD
PremiumThe Fly
ProMIS Neurosciences exceeds target enrollment in PRECISE-AD
6M ago
PMN
ProMIS Neurosciences Regains Nasdaq Compliance
PremiumCompany Announcements
ProMIS Neurosciences Regains Nasdaq Compliance
6M ago
8K
PMN
ProMIS Neurosciences announces publication highlighting PMN310
PremiumThe Fly
ProMIS Neurosciences announces publication highlighting PMN310
6M ago
PMN
ProMIS Neurosciences: Buy Rating Backed by Innovative EpiSelect™ Platform and Promising PMN310 Candidate
PremiumRatingsProMIS Neurosciences: Buy Rating Backed by Innovative EpiSelect™ Platform and Promising PMN310 Candidate
6M ago
PMN
ProMIS Neurosciences: Buy Rating Affirmed Amid Promising PMN310 Progress and Favorable Valuation
Premium
Ratings
ProMIS Neurosciences: Buy Rating Affirmed Amid Promising PMN310 Progress and Favorable Valuation
6M ago
PMN
ProMIS Neurosciences target adjusted to $18 from $4 at H.C. Wainwright
Premium
The Fly
ProMIS Neurosciences target adjusted to $18 from $4 at H.C. Wainwright
6M ago
PMN
ProMIS Neurosciences announces publication on plasma pTau in Alzheimer’s
PremiumThe Fly
ProMIS Neurosciences announces publication on plasma pTau in Alzheimer’s
6M ago
PMN
Promis Neurosciences Inc trading halted, news pending
PremiumThe Fly
Promis Neurosciences Inc trading halted, news pending
6M ago
PMN
ProMIS Neurosciences Announces Reverse Stock Split
PremiumCompany Announcements
ProMIS Neurosciences Announces Reverse Stock Split
6M ago
8K
PMN
ProMIS Neurosciences announces 1-for-20 reverse stock split
PremiumThe Fly
ProMIS Neurosciences announces 1-for-20 reverse stock split
6M ago
PMN
ProMIS Neurosciences Approves Key Shareholder Proposals
PremiumCompany AnnouncementsProMIS Neurosciences Approves Key Shareholder Proposals
7M ago
8K
PMN
ProMIS Neurosciences price target lowered to $5 from $6 at Guggenheim
Premium
The Fly
ProMIS Neurosciences price target lowered to $5 from $6 at Guggenheim
7M ago
PMN
Promising Advancements in Alzheimer’s Research and Strong Financial Position Support Buy Rating for ProMIS Neurosciences
Premium
Ratings
Promising Advancements in Alzheimer’s Research and Strong Financial Position Support Buy Rating for ProMIS Neurosciences
7M ago
PMN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >